{Reference Type}: Case Reports
{Title}: Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use.
{Author}: Lake-Bakaar G;Milgrom B;Kulig C;Sotelo AK;Speirs J;Meihofer A;
{Journal}: Gastro Hep Adv
{Volume}: 3
{Issue}: 4
{Year}: 2024
暂无{DOI}: 10.1016/j.gastha.2024.02.004
{Abstract}: Ketamine-induced sclerosing cholangitis has been described with chronic intranasal and intravenous use. Our case follows chronic topical use for peripheral neuropathy. It is also uniquely associated with early inflammatory bowel disease, a known complication of primary sclerosing cholangitis.